Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

GSK 1,473.00 -16.00 (-1.07%)
price chart
GlaxoSmithKline settles healthcare fraud case for $3 billion
WASHINGTON GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in U.S.
GlaxoSmithKline to pay $3billion fine after pleading guilty to healthcare ...  Daily Mail
Glaxo Agrees to Pay $3 Billion in Fraud Settlement  New York Times
GSK clinches deal to buy Human Genome for $3 billion
LONDON/BOSTON GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile pursuit of the U.S.
Glaxo to Pay $3 Billion for Human Genome  Bloomberg
3 UK Stocks With US-Style Dividends And No Tax Withholding For A Dividend ...
... British multinationals in three diverse sectors that pay American-style quarterly dividends that remain stable with consistent growth from year to year: Royal Dutch Shell PLC Class B (RDS.
GlaxoSmithKline to pay $3 billion in fines, the largest health care fraud ...
The Justice Department said Monday that GlaxoSmithKline PLC will plead guilty to promoting popular antidepressants Paxil and Wellbutrin for unapproved uses.
Glaxo in $3 Billion Settlement  Wall Street Journal
Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
Law360, New York (July 31, 2012, 7:17 PM ET) -- GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co.
Big Pharma is in big trouble – or at least it should be
PETER HITCHENS: They sold us 'happy pills' - but all we got was suicide and misery Landmark: GlaxoSmithKline Plc has agreed to plead guilty to criminal charges and pay $3billion GlaxoSmithKline to pay $3billion fine after pleading guilty to healthcare ...
Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources
Human Genome, which last week agreed to be bought by British drugmaker GlaxoSmithKline Plc for $14.25 per share -- or $3 billion -- said in a filing with regulators last week that the company had received, and rebuffed, a preliminary takeover bid at ...
Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla in Test
GlaxoSmithKline Plc marketed the first HIV drug a quarter century ago before losing out to Gilead Sciences Inc. as the world's biggest maker of AIDS medicines.
Q2 Earnings Report: GlaxoSmithKline, Eli Lilly and Bristol Myers Squibb
GlaxoSmithKline plc (NYSE:GSK) reported an EPS of 40 cents for the quarter ending on June 30th, while diluted per share earnings were 39.7 cents, which misses the analysts' estimates.
Earnings Preview: Bristol-Myers Squibb Company  Seeking Alpha
Glaxo Tries to Shake Marketing Questions on Advair
GlaxoSmithKline GSK 1.78 % PLC's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair—the company's biggest moneymaker and one of the top-selling drugs in the world.